# ATHOS KG

> ATHOS KG is a VC fund in Munich backing Health Care, Medical and Biotechnology. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Munich, Germany
- Total investments: 4
- Last investment: Apr 2026
- Lead investor: 25%
- Last updated: Aug 2026

ATHOS KG is a Munich-based single-family office. ATHOS, with its roots in healthcare and life sciences, invests in teams with great scientific competence as well as technology-driven firms that take an entrepreneurial and value-based approach.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 75% |
| Medical | 2 | 50% |
| Biotechnology | 2 | 50% |
| Hospital | 1 | 25% |
| Life Science | 1 | 25% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 25% |
| Series C | 1 | 25% |
| Secondary Market | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 50% |
| France | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Doctolib | Doctolib is an online booking platform and management software provider for doctors in Europe working with 65 000 health practitioners, present in 1 300 health facilities. 25 million patients visit Doctolib website and mobile app every month.For doctors, Doctolib is a full-range service to improve bookings management, reduce no-show and bring newpatients to your office. For patients, Doctolib is a free online service to find a nearby health practitioner and book doctor or dentist appointments 24/24 and 7/7 within a few clicks.Founded in 2013, Doctolib is based out of Paris, France. | $346.2M | Secondary Market | Apr 02, 2026 |  |
| Antheia | Antheia is unlocking the medicinal power of nature. Its synthetic biology platform surpasses the limits of conventional drug discovery and manufacturing through a novel approach to whole-cell engineering —reconstructing complex molecules in yeast to bring to market next-generation plant-inspired medicines. | $24M | Series C | Jan 27, 2026 |  |
| Bambusa Therapeutics | Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies. |  | Series A | Nov 17, 2025 |  |
| Antheia | Antheia is unlocking the medicinal power of nature. Its synthetic biology platform surpasses the limits of conventional drug discovery and manufacturing through a novel approach to whole-cell engineering —reconstructing complex molecules in yeast to bring to market next-generation plant-inspired medicines. | $56M | Series C | Jun 03, 2025 |  |

4 of 4 investments shown.

## Co-investors
- [Global Health Investment Corporation](https://shizune.co/investors/profile/global-health-investment-corporation-f967) — VC Fund, 2 deals together
- [Invus](https://shizune.co/investors/profile/invus) — VC Fund, 2 deals together
- [ADAR1 Capital Management](https://shizune.co/investors/profile/adar1-capital-management) — VC Fund, 1 deal together
- [America’s Frontier Fund](https://shizune.co/investors/profile/america-s-frontier-fund) — VC Fund, 1 deal together
- [A.P. Moller Holding](https://shizune.co/investors/profile/a-p-moller-holding) — VC Fund, 1 deal together
- [Biotechnology Value Fund](https://shizune.co/investors/profile/biotechnology-value-fund) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does ATHOS KG invest in?

ATHOS KG invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Series C stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did ATHOS KG last invest?

The most recent investment recorded for ATHOS KG closed in Apr 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co